Filtern
Dokumenttyp
- Wissenschaftlicher Artikel (2) (entfernen)
Schlagworte
- SARS-CoV-2 (2) (entfernen)
Institut
The outbreak of the COVID-19 pandemic has also led to many conspiracy theories. While the origin of the pandemic in China led some, including former US president Donald Trump, to dub the pathogen “Chinese virus” and to support anti-Chinese conspiracy narratives, it caused Chinese state officials to openly support anti-US conspiracy theories about the “true” origin of the virus. In this article, we study whether nationalism, or more precisely uncritical patriotism, is related to belief in conspiracy theories among normal people. We hypothesize based on group identity theory and motivated reasoning that for the particular case of conspiracy theories related to the origin of COVID-19, such a relation should be stronger for Chinese than for Germans. To test this hypothesis, we use survey data from Germany and China, including data from the Chinese community in Germany. We also look at relations to other factors, in particular media consumption and xenophobia.
Introduction:In patients with common variable immunodeficiency (CVID),immunological response is compromised. Knowledge about COVID‐19 in CVIDpatients is sparse. We, here, synthesize current research addressing the level ofthreat COVID‐19posestoCVIDpatientsandthebest‐known treatments.
Method:Review of 14 publications.
Results:The number of CVID patients with moderate to severe (~29%) andcritical infection courses (~10%), and the number of fatal cases (~13%), areincreased compared to the general picture of COVID‐19 infection. However,this might be an overestimate. Systematic cohort‐wide studies are lacking, andasymptomatic or mild cases among CVID patients occur that can easily remainunnoticed. Regular immunoglobulin replacement therapy was administered inalmost all patients, potentially explaining why the numbers of critical and fatalcases were not higher. In addition, the application of convalescent plasma wasdemonstrated to have positive effects.
Conclusions:COVID‐19 poses an elevated threat to CVID patients. However,only systematic studies can provide robust information on the extent of thisthreat. Regular immunoglobulin replacement therapy is beneficial to combatCOVID‐19 in CVID patients, and best treatment after infection includes theuse of convalescent plasma in addition to common medication.